imiquimod has been researched along with Hives in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacobs, AA; Markus, J; Rosen, T; Snavely, N | 1 |
| Kambe, N; Kim, YG; Matsue, H; Murakami, M; Nakamura, Y; Nishikomiri, R; Nishikomori, R; Núñez, G; Saito, M | 1 |
2 other study(ies) available for imiquimod and Hives
| Article | Year |
|---|---|
Vasodilatory adverse events associated with topical imiquimod 5 percent cream.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aminoquinolines; Angioedema; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Middle Aged; Skin; Skin Neoplasms; Urticaria | 2008 |
Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria.
Topics: Aminoquinolines; Carrier Proteins; Caspases; Familial Mediterranean Fever; Histamine; Humans; Imiquimod; Interferon Inducers; Interleukin-6; Lipopolysaccharides; Lymphocyte Activation; Mast Cells; Neutrophil Infiltration; Neutrophils; NLR Family, Pyrin Domain-Containing 3 Protein; Skin Diseases; Urticaria | 2009 |